glioblastomas
-
Bryn Mawr’s John Furey Stays “Hands-On,” Bio-Tech Firm Triples in Size
It seemed the right thing for John Furey to do—take 20 years of experience in different pharma roles, including as…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
